<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR60">
 <label>60.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Fairhurst</surname>
    <given-names>RA</given-names>
   </name>
   <name>
    <surname>Gerspacher</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Imbach-Weese</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Mah</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Caravatti</surname>
    <given-names>G</given-names>
   </name>
   <name>
    <surname>Furet</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Identification and optimisation of 4, 5-dihydrobenzo [1, 2-d: 3, 4-d] bisthiazole and 4, 5-dihydrothiazolo [4, 5-h] quinazoline series of selective phosphatidylinositol-3 kinase alpha inhibitors</article-title>
  <source>Bioorg Medicinal Chem Lett</source>
  <year>2015</year>
  <volume>25</volume>
  <fpage>3575</fpage>
  <lpage>81</lpage>
  <pub-id pub-id-type="doi">10.1016/j.bmcl.2015.06.067</pub-id>
 </element-citation>
</ref>
